| Last Price | Today's Change | 52-Week Range | Trading Volume |
|---|---|---|---|
| 32.19 | 0.21 (+0.66%) | 23.73 - 35.86 | 1.2 million |
Market data as of 4:02PM 05/17/13. Quotes are delayed by at least 15 min.
| Open | 32.15 |
|---|---|
| Previous Close | 31.98 |
| Day's Range | 31.95 - 32.29 |
| Market Cap | 3.6B |
| Avg Volume (10 Day) | 1.2M |
| Price/Earnings (Trailing 12 Mo.) | 46.7x |
| Earnings Per Share (Trailing 12 Mo.) | 0.69 |
| Dividend Yield | 0.07 (0.87%) |


These seven metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
| Performed well consistently? | Fail |
|---|---|
| Avoids excess debt? | Pass |
| Converting sales to profits? | Fail |
| Shareholder's money handled rationally? | Pass |
| Increased shareholder value? | Pass |
| Consistently increased owner earnings? | Fail |
| Sells at 25% discount to intrinsic value? | Fail |


These eight metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
| Pays a cash dividend? | Fail |
|---|---|
| Room to increase dividends? | Pass |
| Increased earnings over time? | Fail |
| Borrows within reasonable limits? | Fail |
| Stock is undervalued? | Fail |
| Have investors caught on? | Fail |
| Has support of institutional investors? | Pass |
| Has sufficient liquidity? | Pass |
Top Health Insurance Plans Expanded Coverage of the VerifiĀ® Non-Invasive Prenatal Test to Detect Down Syndrome & Other Chromosomal Abnormalities
Business Wire - Tuesday 05/14/2013 8:00 AM ET
PerkinElmer to Present at UBS Global Healthcare Conference
Business Wire - Monday 05/13/2013 4:05 PM ET
PerkinElmer Announces Financial Results for the First Quarter of 2013
Business Wire - Thursday 04/25/2013 4:21 PM ET
| PKI | Industry Range | |
|---|---|---|
| Revenue Growth (1yr) | 6.32% | |
| Net Income Growth (1yr) | -- | |
| Total Debt/Equity | 0.56 | |
| LT Debt/Equity | 0.56 | |
| Earnings Yield | 2.14% | |
| Price/Sales | 1.71 |
| Company | Last | Change |
|---|---|---|
| Covance Inc | 77.33 | +0.59% |
| PAREXEL International Corp | 46.71 | -0.26% |
| Alere Inc | 26.30 | +0.42% |
| ICON PLC | 33.38 | +1.43% |
| WuXi Pharmatech (Cayman) Inc | 20.43 | +0.54% |
Data is delayed by at least 15 min.